Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

...

5 6 7 8 9 10 11 12 Next >

Amgen scraps experimental weight loss pill, moves forward with injection

May 02, 2024

Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double

May 02, 2024

FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic

April 30, 2024

Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.

April 24, 2024

More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says

April 24, 2024

Most people on weight loss drugs are spending less on restaurants and takeout, survey says

April 20, 2024

Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says

April 17, 2024

Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials

April 17, 2024

EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts

April 12, 2024

Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial

April 04, 2024

Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'

April 04, 2024

Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion

April 03, 2024

Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart

March 27, 2024

Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests

March 27, 2024

Viking Therapeutics stock jumps 15% on promising weight loss pill data

March 26, 2024

Amgen wants in on the booming weight loss drug market — and it's taking a different approach

March 24, 2024

Two fresh ways to play the weight loss and megacap tech hype

March 23, 2024

Here's how much people are willing to spend on weight loss drugs, according to a new survey

March 23, 2024

Cramer's Lighting Round: Arm is a buy

March 22, 2024

Medicare can now cover certain weight loss drugs in a big step for patients

March 21, 2024

Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming

March 19, 2024

Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet

March 16, 2024

FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease

March 14, 2024

Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit

March 14, 2024

Experts hesitate on weight loss ETFs amid the obesity drug boom

March 13, 2024

Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients

March 13, 2024

Jim Cramer reviews Citi's European 'Super Seven'

March 08, 2024

Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage

March 08, 2024

Novo Nordisk CEO says experimental weight loss pill could become a best in class drug

March 08, 2024

Novo Nordisk market cap surpasses Tesla on new obesity pill trial data

March 08, 2024

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.